drugset / Trial / NCT01474213

Sedation Effect of Dexmedetomidine Versus Remifentanil to Fibreoptic Intubation

NCT01474213 ↗

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The purpose of this study is to compare the sedation effect of dexmedetomidine and target controlled remifentanil for awake nasotracheal fibreoptic intubation in patients undergoing oral maxillofacial surgery.

Timeline

Start
2011-11
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.7 ug/kg —
Comparator Remifentanil Small molecule 3.5 ng/ml —
Comparator Remifentanil Small molecule 4 ng/ml —

Indications

No indication recorded.